Search Results Search Sort by RelevanceMost Recent State of the Art and Science Mar 2021 Piloting and Scaling a Good Health Equity Evidence Base From Big Data Stephen Lockhart, MD, PhD One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable. AMA J Ethics. 2021;23(3):E252-257. doi: 10.1001/amajethics.2021.252. State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711. State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711. State of the Art and Science May 2021 What We Know About Long-acting Injectable Antipsychotics Can Help Innovate HIV Care Olivia S. Kates, MD Long-acting injectables powerfully augment HIV care, but broad acceptance and uptake could be compromised by what we know about experiences with antipsychotics. AMA J Ethics. 2021;23(5):E405-409. doi: 10.1001/amajethics.2021.405. State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. State of the Art and Science Nov 2017 Social Media Channels in Health Care Research and Rising Ethical Issues Samy A. Azer, MD, PhD, MEd, MPH Using social media tools in health-related research involves challenges to confidentiality, privacy, and consent. AMA J Ethics. 2017;19(11):1061-1069. doi: 10.1001/journalofethics.2017.19.11.peer1-1711. State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945. State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645. State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
State of the Art and Science Mar 2021 Piloting and Scaling a Good Health Equity Evidence Base From Big Data Stephen Lockhart, MD, PhD One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable. AMA J Ethics. 2021;23(3):E252-257. doi: 10.1001/amajethics.2021.252.
State of the Art and Science Nov 2017 How Should Organizations Promote Equitable Distribution of Benefits from Technological Innovation in Health Care? Satish Nambisan, PhD and Priya Nambisan, PhD Fair distribution demands new strategies for engaging patients in co-creation. AMA J Ethics. 2017;19(11):1106-1115. doi: 10.1001/journalofethics.2017.19.11.stas1-1711.
State of the Art and Science Nov 2017 Why Aren’t Our Digital Solutions Working for Everyone? Brian Van Winkle, MBA, Neil Carpenter, MBA, and Mauro Moscucci, MD, MBA To fairly distribute the benefits of digital technologies, clinicians will need to be incentivized to adopt technologies that target the underserved. AMA J Ethics. 2017;19(11):1116-1124. doi: 10.1001/journalofethics.2017.19.11.stas2-1711.
State of the Art and Science May 2021 What We Know About Long-acting Injectable Antipsychotics Can Help Innovate HIV Care Olivia S. Kates, MD Long-acting injectables powerfully augment HIV care, but broad acceptance and uptake could be compromised by what we know about experiences with antipsychotics. AMA J Ethics. 2021;23(5):E405-409. doi: 10.1001/amajethics.2021.405.
State of the Art and Science Aug 2021 How Economic Decision Modeling Can Facilitate Health Equity Jeffrey S. Hoch, PhD, Logan Trenaman, PhD, Shannon M. Hearney, MPH, and Carolyn S. Dewa, PhD, MPH Modeling how technology assessment fits into cost-effectiveness frameworks can broaden the range of options for improving health equity. AMA J Ethics. 2021;23(8):E624-630. doi: 10.1001/amajethics.2021.624.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.
State of the Art and Science Nov 2017 Social Media Channels in Health Care Research and Rising Ethical Issues Samy A. Azer, MD, PhD, MEd, MPH Using social media tools in health-related research involves challenges to confidentiality, privacy, and consent. AMA J Ethics. 2017;19(11):1061-1069. doi: 10.1001/journalofethics.2017.19.11.peer1-1711.
State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945.
State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645.
State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654.